- Home
- FPAY vs BRNS Comparison
FPAY vs BRNS Comparison
Compare FPAY & BRNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FPAY
- BRNS
- Stock Information
- Founded
- FPAY 2003
- BRNS 2016
- Country
- FPAY United States
- BRNS United Kingdom
- Employees
- FPAY N/A
- BRNS N/A
- Industry
- FPAY Diversified Commercial Services
- BRNS Biotechnology: Pharmaceutical Preparations
- Sector
- FPAY Consumer Discretionary
- BRNS Health Care
- Exchange
- FPAY Nasdaq
- BRNS Nasdaq
- Market Cap
- FPAY 46.4M
- BRNS 41.0M
- IPO Year
- FPAY N/A
- BRNS 2021
- Fundamental
- Price
- FPAY $1.66
- BRNS $1.04
- Analyst Decision
- FPAY Strong Buy
- BRNS Strong Buy
- Analyst Count
- FPAY 2
- BRNS 2
- Target Price
- FPAY $3.25
- BRNS $3.00
- AVG Volume (30 Days)
- FPAY 409.0K
- BRNS 46.0K
- Earning Date
- FPAY 11-14-2024
- BRNS 11-06-2024
- Dividend Yield
- FPAY N/A
- BRNS N/A
- EPS Growth
- FPAY N/A
- BRNS N/A
- EPS
- FPAY N/A
- BRNS N/A
- Revenue
- FPAY $134,563,007.00
- BRNS $14,969,000.00
- Revenue This Year
- FPAY $25.78
- BRNS $1,805.74
- Revenue Next Year
- FPAY $6.46
- BRNS N/A
- P/E Ratio
- FPAY N/A
- BRNS N/A
- Revenue Growth
- FPAY 24.46
- BRNS 106.21
- 52 Week Low
- FPAY $0.97
- BRNS $0.80
- 52 Week High
- FPAY $2.37
- BRNS $4.16
- Technical
- Relative Strength Index (RSI)
- FPAY 47.07
- BRNS 48.42
- Support Level
- FPAY $1.60
- BRNS $0.91
- Resistance Level
- FPAY $2.37
- BRNS $1.15
- Average True Range (ATR)
- FPAY 0.20
- BRNS 0.15
- MACD
- FPAY -0.02
- BRNS -0.01
- Stochastic Oscillator
- FPAY 24.47
- BRNS 34.96
About FPAY FlexShopper Inc.
FlexShopper Inc is a financial technology company engaged in providing certain types of durable goods to consumers on a lease-to-own basis and providing lease-to-own (LTO) terms to consumers of third-party retailers and e-tailers. Its products include electronics, computers, furniture, mattresses, cameras and camcorders, audio, musical instruments, health, fitness and sports, video games, homes, gardens and tools, appliances, and vacuums on a payment, lease basis. The firm generates a majority of its revenue by leasing its products. The company enables consumers utilizing its e-commerce marketplace to shop for brand-name electronics, home furnishings, and other durable goods on a lease-to-own (LTO) basis.
About BRNS Barinthus Biotherapeutics plc
Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company developing novel T cell immunotherapeutic that guide the immune system to overcome chronic infectious diseases, autoimmunity and cancer.